VIEMED HLTHCARE INC. O.N.
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more
VIEMED HLTHCARE INC. O.N. (VIJ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, VIEMED HLTHCARE INC. O.N. (VIJ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
VIEMED HLTHCARE INC. O.N. - Net Assets Trend (None–None)
This chart illustrates how VIEMED HLTHCARE INC. O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for VIEMED HLTHCARE INC. O.N. (None–None)
The table below shows the annual net assets of VIEMED HLTHCARE INC. O.N. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to VIEMED HLTHCARE INC. O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
VIEMED HLTHCARE INC. O.N. Competitors by Market Cap
The table below lists competitors of VIEMED HLTHCARE INC. O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mennica Polska S.A.
WAR:MNC
|
$243.46 Million |
|
STHREE PLC LS -01
F:S8T
|
$243.47 Million |
|
Black Box Limited
NSE:BBOX
|
$243.59 Million |
|
Heba Fastighets AB Series B
LSE:0GNV
|
$243.62 Million |
|
RDC Semiconductor Co Ltd
TWO:3228
|
$243.42 Million |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
$243.38 Million |
|
Rezolve AI PLC
F:O5F
|
$243.36 Million |
|
Zhejiang Zhengyuan Zhihui Technology Co Ltd
SHE:300645
|
$243.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in VIEMED HLTHCARE INC. O.N.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares VIEMED HLTHCARE INC. O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently VIEMED HLTHCARE INC. O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares VIEMED HLTHCARE INC. O.N.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| VIEMED HLTHCARE INC. O.N. (VIJ) | €- | N/A | N/A | $243.43 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |